XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Activities:      
Net Income (Loss) $ 166,060 $ (43,355) $ (187,766)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:      
Gain on Disposition of Hotel Properties (197,505) (48,352) (1,158)
Gain from Sale of Interest in Unconsolidated Joint Ventures (5,167) 0 0
Loss on Impairment of Assets 10,113 222 5,488
Insurance Recoveries in Excess of Property Loss (933) (711) (8,960)
Junior Note PIK Interest Added to Principal 1,855 6,239 0
Deferred Taxes 0 0 11,290
Depreciation 64,715 82,973 96,527
Amortization 4,657 5,314 3,540
Loss on Debt Extinguishment 14,312 634 0
Equity in Loss of Unconsolidated Joint Ventures 53 2,292 2,938
(Gain) Loss Recognized on Change in Fair Value of Derivative Instrument (1,264) (1,124) 2,590
Share Based Compensation Expense 14,384 12,033 9,488
Proceeds Received for Business Interruption Insurance Claims, net 0 0 4,411
(Increase) Decrease in:      
Hotel Accounts Receivable (431) (2,801) 3,523
Other Assets (9,328) (6,781) 7,738
Due from Related Parties 2,250 146 3,472
(Decrease) Increase in:      
Due to Related Parties 887 1,723 0
Accounts Payable, Accrued Expenses and Other Liabilities 10,910 7,780 (10,586)
Net Cash Provided by (Used in) Operating Activities 75,568 16,232 (57,465)
Investing Activities:      
Capital Expenditures (23,587) (10,873) (26,340)
Cash Paid for Hotel Development Projects 0 0 21
Proceeds from Disposition of Hotel Properties 526,828 163,583 19,591
Contributions to Unconsolidated Joint Ventures (485) (1,489) (1,125)
Proceeds from Insurance Claims 1,294 0 6,338
Proceeds from the Sale of Joint Venture Interests 6,191 0  
Distributions from Unconsolidated Joint Ventures 0 250 0
Net Cash Provided by (Used in) Investing Activities 510,241 151,471 (1,515)
Financing Activities:      
Borrowings on Line of Credit and Term Loans 400,000 13,500 88,000
Repayments on Line of Credit (118,684) (27,869) (2,947)
Payments on Term Loans (524,628) (187,024) (16,395)
Principal Repayment of Mortgages and Notes Payable (160,287) (24,186) (1,684)
Proceeds from Mortgages and Notes Payable 0 167,750 0
Deferred Financing Costs (4,139) (6,231) (3,188)
Cash Paid for Debt Extinguishment (6,497) 0 0
Dividends Paid on Common Shares (1,975) 0 (10,809)
Dividends Paid on Preferred Shares (24,174) (42,305) (6,044)
Distributions Paid on Common Units and LTIP Units (350) 0 (1,198)
Other Financing Activities 0 0 (133)
Net Cash (Used in) Provided by Financing Activities (440,734) (106,365) 45,602
Net Increase (Decrease) in Cash and Cash Equivalents 145,075 61,338 (13,378)
Cash, Cash Equivalents, and Restricted Cash - Beginning of Year 84,945 23,607 36,985
Cash, Cash Equivalents, and Restricted Cash - End of Year $ 230,020 $ 84,945 $ 23,607